VolitionRx Limited (NYSE:VNRX) Q4 2021 Results Conference Call March 31, 2022 8:00 AM ET Company Participants Scott Powell - Executive Vice President of Investor Relations Cameron Reynolds - President and Chief Executive Officer Terig Hughes - Chief Financial Officer Tom Butera - Chief Executive Officer, Volition Veterinary Diagnostics Development Conference Call Participants Ross Osborn - Cantor Fitzgerald Bruce Jackson - The Benchmark Company Nathan Weinstein - Aegis Capital Michael Okunewitch - Maxim Ope ...